SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Dadra Facility Receives Warning Letter From US FDA

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Expensive Performer

1838.8000 9.40 (0.51%)

NSE May 05, 2025 11:29 AM

33.52% Gain from 52W Low

Volume: 497.2K

Sun Pharmaceutical Industries Ltd.

19 Jun 2024

1838.80

0.51%

Company Update

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Intimation regarding Warning Letter from US FDA

More from Sun Pharmaceutical Industries Ltd.

Recommended

Market trades higher, State Bank of India's net profit declines 9.9% YoY to Rs 18,642.6 crore in Q4

Trendlyne Marketwatch | 05 May 2025, 11:27AM

Five Interesting Stocks Today - May 02, 2025

The Baseline | 02 May 2025

Change is hard, and some Indian pharma companies are embracing it better than others